MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Bibliographic Details
Main Author:	DEVELOPMENT GROUP MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MOH MALAYSIA
Format:	Article
Language:	English
Published:	Academy of Family Physicians of Malaysia 2011-01-01
Series:	Malaysian Family Physician
Online Access:	http://www.e-mfp.org/2011v6n1/pdf/Major_depressive_disorder.pdf

Similar Items

MANAGEMENT OF SCHIZOPHRENIA IN ADULTS
by: DEVELOPMENT GROUP CPG MANAGEMENT OF SCHIZOPHRENIA MOH MALAYSIA
Published: (2011-01-01)

The neurocognitive profile of post‐traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
by: Sheri‐Michelle Koopowitz, et al.
Published: (2021-04-01)

Prevalence and clinical characteristics of major depressive disorder (MDD) without depressed mood in Koreans with MDD: results from the CRESCEND study
by: Seon-Cheol Park, et al.
Published: (2017-10-01)

Pharmacogenetics of Major Depressive Disorder (MDD): Progress in Two Serotonergic Targets
by: Chidiebere Michael Iro, et al.
Published: (2018-11-01)

Identifying Early Maladaptive Schema of Patients with Major Depressive Disorder (MDD)
by: Mosayeb yarmohammadi vasel, et al.
Published: (2019-01-01)

Comparing the Efficacy of Fluvoxamine and Sertraline in Treating Major Depressive Disorder (MDD)
by: Seyed-Saeid Hasani-Tabatabaei, et al.
Published: (2013-12-01)

MANAGEMENT OF DENGUE INFECTION IN ADULTS
by: DEVELOPMENT GROUP CPG MANAGEMENT OF DENGUE INFECTION IN ADULTS MOH MALAYSIA
Published: (2011-01-01)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-04-01)

Skin conductance responses in Major Depressive Disorder (MDD) under mental arithmetic stress.
by: Ah Young Kim, et al.
Published: (2019-01-01)

Synergistic effects of ketamine and theta burst stimulation in the treatment of major depressive disorder (MDD)
by: A.F. Leuchter, et al.
Published: (2017-03-01)

S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review
by: Alessandro Cuomo, et al.
Published: (2020-09-01)

Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
by: Michael Leutner, et al.
Published: (2021-02-01)

Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder.
by: Aleix Arnau-Soler, et al.
Published: (2018-01-01)

Cognitive control functions in unipolar major depression (MDD) with and without co-morbid anxiety disorder
by: Pia Lyche, et al.
Published: (2010-12-01)

Corrigendum: Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
by: Michael Leutner, et al.
Published: (2021-04-01)

Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects
by: Miguel A. Alvarez-Mon, et al.
Published: (2021-08-01)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-07-01)

MK4MDD: a multi-level knowledge base and analysis platform for major depressive disorder.
by: Liyuan Guo, et al.
Published: (2012-01-01)

The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson’s Disease (PD) and Major Depressive Disorder (MDD)
by: Kai Yang, et al.
Published: (2019-05-01)

PHQ-8 Days: a measurement option for DSM-5 Major Depressive Disorder (MDD) severity
by: Balluz Lina S, et al.
Published: (2011-04-01)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
by: Novick D, et al.
Published: (2017-10-01)

Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents with Major Depressive Disorder (MDD)
by: Christopher A Wall, et al.
Published: (2013-12-01)

MANAGEMENT OF HYPERTENSION
by: WORKING GROUP CPG MANAGEMENT OF HYPERTENSION MOH MALAYSIA
Published: (2011-01-01)

A gene co-expression network-based analysis of multiple brain tissues reveals novel genes and molecular pathways underlying major depression.
by: Zachary F Gerring, et al.
Published: (2019-07-01)

The Relationship Between Coronary Heart Disease (CHD) and Major Depressive Disorder (MDD): Key Mechanisms and the Role of Quality of Life
by: Adrienne O’Neil
Published: (2013-02-01)

Applying Inner Wisdom to Amelioration Status of Major Depressive Disorder (MDD) for Elderly People Age Group in Mahasarakham Province
by: Janphen Phusopha, et al.
Published: (2018-12-01)

Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocol
by: F. Matcham, et al.
Published: (2019-02-01)

Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group
by: Jeanne Leerssen, et al.
Published: (2020-12-01)

Altered resting-state dynamic functional brain networks in major depressive disorder: Findings from the REST-meta-MDD consortium
by: Yicheng Long, et al.
Published: (2020-01-01)

Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
by: Crawford Gordon M, et al.
Published: (2011-03-01)

The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.
by: Xinghua Ding, et al.
Published: (2014-01-01)

Audio-Guided Mindfulness Meditation During TMS Sessions for the Treatment of Major Depressive Disorder (MDD): A Feasibility Pilot Study
by: Eric Tirrell, et al.
Published: (2020-11-01)

The relationship between the individual alpha frequency (IAF) and response to synchronized transcranial magnetic stimulation (sTMS) for treatment of major depressive disorder (MDD)
by: A.F. Leuchter, et al.
Published: (2017-03-01)

Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD): a systematic overview of randomized controlled trials
by: Pontén, Emeli
Published: (2015)

One session of Repetitive Transcranial Magnetic Stimulation (rTMS) can improve catatonia features associated with Major Depressive Disorder (MDD): Case study
by: A. Marei, et al.
Published: (2017-03-01)

The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD)
by: Juliana Corlier, et al.
Published: (2019-11-01)

Deep transcranial magnetic stimulation (dTMS) for treatment of major depressive disorder (MDD) status post-surgical removal of medulloblastoma: A case report of safety
by: Jagdeep Kaur, et al.
Published: (2019-07-01)

Poly ADP-Ribose Protein (PARP) Inhibition Alleviates Behavioral Endophenotypes Due to Stress in a Rodent Double-Hit Model of Major Depressive Disorder (MDD)
by: De Preter, Caitlynn
Published: (2017)

Effectiveness of Islamic Quality of Life Therapy on Quality of Life and Depression in Students with MDD
by: MY Seifi Gandomani, et al.
Published: (2016-05-01)

The comparison of Anger and Sense of Guilt in Individuals with Major Depres-sion Disorder (MDD) and Post Trau-matic Stress Disorder (PTSD) with the Normal people
by: M. Rajabi, et al.
Published: (2013-02-01)